Stocktoria
Mineralys Therapeutics, Inc. MLYS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-02-10
Mineralys Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,911,433 | $51.8M | 2.34% |
| D. E. Shaw & Co., Inc. | 887,192 | $24.0M | 1.09% |
| BlackRock Finance, Inc. | 2,045,702 | $23.9M | 2.51% |
| CITADEL ADVISORS LLC | 763,141 | $20.7M | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 525,260 | $14.2M | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 382,800 | $10.4M | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 311,488 | $8.4M | 0.38% |
| AQR CAPITAL MANAGEMENT LLC | 149,086 | $4.0M | 0.18% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.